Industry News
Global CAR T-cell Therapy Development Pro…
Chimeric antigen receptor (CAR) T-cell therapy is a type of treatment to get T cells (a type of immune system cell) to fight cancer by changing them in the laboratory so they can find and at…
AIDS Candidate Drug GS-CA1 Shows Signific…
GS-CA1, an inhibitor of the HIV capsid, can provide long-term protection with one injection and prevent macaques from being infected with Simian-Human Immunodeficiency Virus (SHIV).
Vaccine Is Expected to Be Launched Early …
Last Friday (November 26), WHO urgently announced the fifth type of VOC, named after the Greek letter Omicron, the variant also goes by the scientific name B.1.1.529.
Sitagliptin - First In Class DPP4 Inhibit…
Sitagliptin, the first oral DPP-4 inhibitor to be marketed for treating Type 2 Diabetes
What Are PEG Linkers and Their Applicatio…
Learn more detailes about PEG linkers and its applications in pharmaceutical field.
Ten Most Popular Anti-cancer Drugs In 202…
In view of the complexity of cancer treatment and peoples needs, the market prospects of anti-tumor drugs are broad. Many pharmaceutical and biotechnology companies have stepped up research a…
Antibody-Drug Conjugates for Cancer Thera…
Antibody-drug conjugates (ADCs) are a rapidly evolving class of anticancer therapeutics consisting of antibodies attached to potent cytotoxic drugs via chemical linkers.
CDK4/6 Inhibitors for Treatment of Advanc…
There are three CDK4/6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib approved by FDA to treat Advanced Breast Cancer.
sales@huatengusa.com
+86 0731 89916275